Table 5 |
|
Lymphatic Filariasis elimination and the Millennium Development Goals |
|
Goal 1 |
|
• Eliminate extreme poverty and hunger |
|
• LF is a disease of poor people in poor countries, particularly in individuals earning below $1/day. LF elimination reduces health care costs and increases productivity |
|
• Reduces prevalence of underweight children by improving nutritional status, micronutrient uptake enhanced through albendazole and by improvement of agricultural productivity and improving household/community food security |
|
Goal 2 |
|
• Achieve universal primary education |
|
• LF elimination will increase capacity of poor families to access education through increased income, reduced caring for afflicted parents, increased school attendance and performance via drug treatment impact on intestinal helminths |
|
• Schools can act as an entry point for drug distribution, increasing both coverage and parental awareness of the benefits |
|
Goal 3 |
|
• Promote gender equity and empowerment |
|
• Women play a role as drug distributors enhancing respect and empowerment |
|
• Women's marital prospects enhanced as LF control reduces stigma of disease |
|
Goal 4 and Goal 5 |
|
• Reduce child mortality and reduce maternal mortality |
|
• Women's health status improves as albendazole alleviates hookworm anaemia |
|
• Anaemia → better birth outcomes → reduced prevalence of low birth weight babies hence reduced maternal and infant mortality |
|
Goal 6 |
|
• Combat HIV/AIDS/malaria and other diseases |
|
• LF and malaria control interlinked by bednets, alleviation of anaemia by albendazole; drug distribution can enhance bednet coverage and re-impregnation rates |
|
• Albendazole impacts on child and maternal mortality via alleviation of anaemia burden |
|
Goal 7 and Goal 8 |
|
• Ensure environmental sustainability |
|
• Develop a Global partnership for Development |
|
• GAELF and GPELF are an effective diverse global partnership committed to elimination of a disease of poverty by 2020. |
|
• Elimination has been achieved in several countries bringing development benefits to poor communities |
|
|
|
Molyneux Filaria Journal 2003 2:13 doi:10.1186/1475-2883-2-13 |